Bradley Merrill Thompson, Member of the Firm in the Health Care & Life Sciences practice, in the firm’s Washington, DC, office, was quoted in BioPharma Dive, in “Biden Nominates Robert Califf to Return as FDA Head,” by Ned Pagliarulo and Jonathan Gardner.
Following is an excerpt:
President Joe Biden on Friday nominated former Food and Drug Administration head Robert Califf to return to the agency as its commissioner, choosing a familiar name to lead the regulator after a drawn-out search.
Califf, a cardiologist and prolific researcher, served as FDA commissioner for less than a year at the end of the Obama administration. After leaving government, he advised Google and its health spinoff Verily Life Sciences, taking a job leading health policy there in November 2019. …
Bradley Merrill Thompson, attorney at the law firm Epstein Becker Green, described Califf as "extraordinarily knowledgeable" about digital health issues.
"Cardiology is the second most popular therapeutic area for AI, interpreting EKG waveforms and such. He also obviously has strong regulatory knowledge which helps him hit the ground running," Thompson said. …